Bacteriology and in vitro antimicrobial susceptibility of the Pseudomonas fluorescens group isolated from clinical specimens.
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002228:Carbenicillin / Q000494:pharmacology; D002512:Cephalothin / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D009268:Nalidixic Acid / Q000494:pharmacology; D009582:Nitrofurantoin / Q000494:pharmacology; D010403:Penicillin Resistance; D011113:Polymyxins / Q000494:pharmacology; D011551:Pseudomonas fluorescens / Q000187:drug effects*; D013183:Sputum / Q000382:microbiology; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014556:Urine / Q000382:microbiology
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D011113:Polymyxins; D009268:Nalidixic Acid; D007612:Kanamycin; D002701:Chloramphenicol; D000667:Ampicillin; D009582:Nitrofurantoin; D013752:Tetracycline; D002228:Carbenicillin; D002512:Cephalothin; D013307:Streptomycin